1. Endobronchial Valves in the Management of Persistent Air Leak in Coronavirus Disease 2019
- Author
-
Hassan Kattach, Lukacs Veres, Abdul Badran, Hanad Ahmed, Aiman Alzetani, and Alessandro Tamburrini
- Subjects
Pulmonary and Respiratory Medicine ,ARDS ,medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,business.industry ,viruses ,fungi ,virus diseases ,medicine.disease ,humanities ,respiratory tract diseases ,Surgery ,law.invention ,Pneumonia ,Pneumothorax ,law ,Fraction of inspired oxygen ,Ventilation (architecture) ,medicine ,Persistent air leak ,Cardiology and Cardiovascular Medicine ,business ,Positive end-expiratory pressure - Abstract
Pneumothorax and persistent air leak (PAL) are documented complications of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. Patients that fall in this category are often poor candidates for invasive thoracic surgical intervention. Endobronchial valves offer an effective and less invasive treatment option and can successfully treat PAL and support the weaning of patients with SARS-CoV-2 pneumonia off ventilation.
- Published
- 2022
- Full Text
- View/download PDF